Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: Spero rapeutics - What They Never Told You

Spero Therapeutics' Shares Plunge As FDA Issued Refusal Letter For Urinary Tract Infection Candidate

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

Recap: Spero Therapeutics Q1 Earnings

Recap: Spero Therapeutics Q1 Earnings

Spero Therapeutics (NASDAQ:SPRO) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

A Preview Of Spero Therapeutics's Earnings

Spero Therapeutics (NASDAQ:SPRO) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Spero Therapeutics will report an earnings per share (EPS) of $-0.75.

1

Organisations

B of A Securities

Evercore ISI Group

Akamai Technologies

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play